Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3077-3083
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3077
Table 2 Pathological data n (%)
DiagnosisGroup LEGroup YEGroup AP value
Malignant tumors68 (71)67 (70)68 (71)NS
PDAC49 (51)47 (49)54 (56)NS
Ampullary carcinoma12 (12)10 (10)8 (8)NS
Cholangiocarcinoma3 (3)5 (5)1 (1)NS
Clear cell renal carcinoma01 (1)1 (1)NS
Duodenal carcinoma2 (2)1 (1)4 (4)NS
Others2 (2)3 (3)0NS
Benign conditions28 (29)29 (30)28 (29)NS
Cystic tumors16 (17)18 (19)10 (10)NS
pNET4 (4)4 (4)5 (5)NS
Chronic pancreatitis04 (4)4 (4)NS
GIST1 (1)02 (2)NS
Others7 (7)3 (3)7 (7)NS
Total96 (100)96 (100)96 (100)NA

  • Citation: Paiella S, De Pastena M, Pollini T, Zancan G, Ciprani D, De Marchi G, Landoni L, Esposito A, Casetti L, Malleo G, Marchegiani G, Tuveri M, Marrano E, Maggino L, Secchettin E, Bonamini D, Bassi C, Salvia R. Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center. World J Gastroenterol 2017; 23(17): 3077-3083
  • URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3077.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3077